You are viewing this site with an unsupported web browser! All content should exist but may not be displayed optimally.

Directional Atherectomy

What is Directional Atherectomy?

The TurboHawk Device is a catheter-based device that includes a directional cutter that can be positioned to address the area of greatest plaque burden within a vessel and maximize luminal gain for better results.1 The High Efficiency Cutter in the device can now treat all plaque morphologies — above and below the knee.2

How Prevalent is PAD?

Despite its pathophysiology, PAD is still largely undiagnosed. Of the estimated 8 to 12 million Americans that suffer from the disease, only about 25% are treated.3

Getting Started

Covidien makes it easy for clinicians to get started and offer this technology to patients. Talk with your local sales representative about our PACE program-sponsored educational opportunities that include didactic learning, small group discussions, hands-on training, case observations, and dinner programs where you can learn more about the clinical evidence that supports the therapy.

If you are a healthcare professional interested in more information, please contact us.

  1. Aboufakher R, Torey J, Szpunar S, et al. Peripheral Plaque Volume Changes Pre- and Post-rotational Atherectomy followed by Directional Plaque Excision: Assessment by Intravascular Ultrasound and Virtual Histology. J Invasive Cardiol. 2009;21:501-505.
  2. Large vessel catheters: When used in hard, complex calcified lesions the TurboHawk catheter should be paired with SpiderFX™ Embolic Protection Device to mitigate the risk of distal embolization. Small vessel catheters: Do not use in hard, complex calcified lesions due to the risk of distal embolization that may result from excising this type of lesion.

Indications, contraindications, warnings, and instructions for use can be found in the product labeling supplied with each device.
CAUTION: Federal (USA) Law restricts this device to sale by or on the order of a physician.